The Food and Drug Administration today published a proposed rule that would update requirements under the Mammography Quality Standards Act of 1992, which authorized FDA oversight of mammography facilities. According to the agency, the rule would expand the information that mammography facilities must provide to patients and health care professionals, modernize mammography quality standards and enhance facility oversight. For example, the rule would require that the facility report information on breast density in the report to the clinician and the patient’s summary letter to enable patients and their doctors to have a more informed discussion about the enhanced risks associated with dense breasts if appropriate. The agency will accept comments on the proposed rule for 90 days.

Related News Articles

Headline
Hartford HealthCare in Hartford, Conn., will receive the 2025 AHA Quest for Quality Prize as a result of their sweeping transformation over the past decade —…
Headline
A Q&A in the July edition of AHA Trustee Insights features leaders from Winchester Hospital in Massachusetts discussing the importance of board members…
Headline
To help hospitals across the country improve sepsis care, the Centers for Disease Control and Prevention created the Hospital Sepsis Program Core Elements,…
Headline
The Centers for Medicare & Medicaid Services July 10 announced it will provide resources and flexibilities to health care providers and residents who…
Headline
AHA President and CEO Rick Pollack explains how hospitals have made meaningful progress in patient safety and delivering high-quality care, in a column…
Headline
The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury…